Shares of Eli Lilly & Co. LLY shed 1.44% to $807.58 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.94% to 6,033.11 and the ...

The company said the boil notice is due to a low water pressure incident on the Nacogdoches side of the water system.

Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...

STORY: Eli Lilly said Monday it will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying ...

Eli Lilly's LLY short percent of float has risen 9.78% since its last report. The company recently reported that it has 8.03 million shares sold short, which is 1.01% of all regular shares that are ...

A growth-focused fund blending momentum and strong earnings. High upside potential with elevated volatility. Best for ...

While stock splits are far from easy to predict, two names stand out for their potential to do so going forward. Those stocks ...

Eli Lilly will add 12.5 mg and 15 mg single-dose vials of its weight loss drug Zepbound to its LillyDirect platform starting July 7, completing the full range of approved doses. All vial doses, ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Discover why Tonix Pharmaceuticals Holding Corp. stock could rally with FDA approval for Tonmya targeting fibromyalgia. Click ...

At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were ...